2022 Speakers Adrian Hobson Senior Research Fellow, Drug Discovery Science & Technology Antibody-Drug Conjugates AbbVie Jin-Chen Yu Senior Vice President, Preclinical Research Bio-Thera Solutions Nicolas Camper Group Leader & Bioconjugate Chemistry Abzena Yu Shen Director, Oncology Discovery AbbVie John Boylan Vice President, Scientific Strategy Exelixis John Lambert Consultant Attager Consulting Rakesh Dixit Chief Executive Officer Bionavigen Sayumi Yamazoe Senior Principal Scientist Bristol-Myers Squibb Anikó Pálfi Director, Biochemistry & Cell Biology Heidelberg Pharma Research GmbH Christopher Shelton Scientific Director, Tumor Cell Targeting Research Unit GlaxoSmithKline Hanspeter Gerber Chief Scientific Officer Codeable Therapeutics Robert Lutz Chief Scientific Officer Iksuda Therapeutics Dowdy Jackson Executive Director, ADC Biology Research Innovent Biologics John DaSilva Associate Director, Oncology & Immuno-Oncology Regeneron Robert Lawrence Senior Scientist Seagen Thomas Nittoli Senior Director, R&D Chemistry Regeneron Annette Vogl Director, Biology & Translational Research Tubulis GmbH Daniele Biasci Consulting VP, Immunology Absci John Boylan Vice President, Scientific Strategy Exelixis Laurence Madera Senior Scientist Zymeworks Mark Gustavson Senior Director, Oncology Translational Medicine AstraZeneca